340 Stories, most recent news story added 2 hours 18 minutes ago
Being diagnosed with juvenile rheumatoid arthritis at the age of 14 hasn’t slowed down Gabriela Guefen. Despite her ailment, she not only plays on her high school volleyball team, but she’s an advocate for other young people who suffer from arthritis as well.
BRUSSELS, December 14 /PRNewswire-FirstCall/ -- - Results From a Survey Conducted by UCB Assessing the Lifestyles of Women With Rheumatoid Arthritis in Seven Major Industrialized Countries - A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of the festive season - Women living with rheumatoid arthritis find shopping for gifts, preparing holiday food ...
A survey of women in the United Kingdom reveals that rheumatoid arthritis has a severe emotional and physical impact on people living with the disease and their families. Feelings of detachment and isolation from those closest to them due to RA are especially prevalent at Christmas, which should be one of the happiest times of the year.
Festive spirits arrived at Old Dominion early this year to celebrate the 22nd Annual Jingle Bell Run/Walk, a benefit for The Arthritis Foundation.
Biogen Idec and Genentech Inc., a wholly owned member of the Roche Group, recently reported positive phase III results on their rheumatoid arthritis candidate, ocrelizumab.
( University of Michigan Health System ) Millions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests.
VAIL, Colorado - It hasn't been that long since the arthritis drug Vioxx was taken off the market for increased risk of stroke and heart attack in some patients. Currently, the manufacturer of the drug Fosamax, which is used in the treatment or prevention of osteoporosis, is involved in a trial with a class-action lawsuit alleging the drug causes osteonecrosis of the jaw, pathological fractures ...
Swiss drugmaker Roche Holding said a late-stage study found its arthritis drug ocrelizumab helped ease symptoms of a type of rheumatoid arthritis.
Leonard Bell, M.D., CEO, Alexion Pharmaceuticals, Inc. David N. Cicilline, Mayor, Providence, RI Stephen Evangelista, President and CEO, Arthritis Foundation of Northern and Southern New England, and Chairman of the Rhode Island Health Advocacy ForumPatrice Dudley-Aviles, Director, Human Resources, Amgen George Nee, President, RI AFL-CIO Peter Snyder, Ph.D., Vice President of Research, Lifespan ...
You can recognize them this time of year: They have chapped lips and hands; they're a bit hunched over and the older ones limp with cold-induced bouts of arthritis and rheumatism. Their faces alternate between stressful concentration and full-fledged joy.
ZURICH -(Dow Jones)- Swiss drug maker Roche Holding AG (ROG.VX), its U.S.- biotech unit Genentech and their partner Biogen Idec Inc. (BIIB) said Friday the rheumatoid arthritis drug candidate ocrelizumab showed positive results in a late-stage trial.
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters